ELS-tíðindi - nóvember 2000

11/2000
Aðgengilegar
umsóknir
Eftirtaldar einkaleyfisumsóknir
eru öllum
aðgengilegar hjá Einkaleyfastofu,
í samræmi við
2. og 4. mgr. 22. gr. laga nr.
17/1991 um einkaleyfi, með
síðari breytingum, að
liðnum 18 mánaða
leyndartíma talið frá
umsóknar- eða
forgangsréttardegi.
(21) 5381
(22) 22.2.2000
(41) 25.8.2000
(51) A61K
(54) 4-fenyl-pyridin afleiður.
(71) F. Hoffmann-La Roche AG, 124
Grenzacherstrasse, CH-4070 Basel,
Sviss.
(72) Michael Bös, Montreal, Quebec,
Kanada; Quirico Branca, Binningen,
Sviss; Guido Galley, Rheinfelden,
Þýskalandi; Thierry Godel, Basel,
Sviss; Torsten Hoffmann, Birsfelden,
Sviss; Walter Hunkeler, Magden,
Sviss; Patrick Schnider, Oberwil,
Sviss; Heinz Stadler, Rheinfelden,
Sviss.
(74) Örn Þór, hrl., Skúlagötu 63, 105
Reykjavík.
(30) 24.2.99, EP, 99103504.9
29.11.99, EP, 99123689.4
(21) 5465
(22) 19.4.2000
(41) 19.4.2000
(51) C07D 231/56; A61K 31/415
(54) Indazól bíóísóster umskipting á
katekóli í meðferðalega virkum
efnasamböndum.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Anthony Marfat, Mystic, Connecticut,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 4.11.97, US, 60/064,229
4.11.97, US, 60/064,187
4.11.97, US, 60/064,024
4.11.97, US, 60/064,228
4.11.97, US, 60/064,198
(85) 19.4.2000
(86) 26.10.98, PCT/IB98/01710
ELS tíðindi 75
(21) 5504
(22) 19.5.2000
(41) 19.5.2000
(51) A61K 31/00
(54) Samsetning virk við meðhöndlun á
getuleysi.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Michael Grant Wyllie, Canterbury,
Kent, Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 16.12.97, US, 60/069,741
(85) 19.5.2000
(86) 29.10.98, PCT/IB98/01723
(21) 5513
(22) 26.5.2000
(41) 26.5.2000
(51) C07D 471/04; C07D 401/06; C07D
401/14; C07D 519/00; A61K 31/415;
A61K 31/44
(54) Intergrín viðtaka mótlyf.
(71) Merck & Co., Inc., 126 East
Lincoln Avenue, Rahway, New
Jersey 07065, Bandaríkjunum.
(72) Mark E. Duggan; Robert S.
Meissner; John H. Hutchinson;
Wasyl Halczenko; Ben C. Askew;
Paul J. Coleman; Michael A. Patane;
Jiabing Wang; Rahway, New Jersey,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 17.12.97, US, 60/069,910
24.3.98, US, 60/079,197
30.3.98, US, 60/079,944
2.4.98, US, 60/080,397
27.4.98, US, 60/083,251
13.5.98, GB, 9810182.7
20.5.98, GB, 9810882.2
20.5.98, GB, 9810892.1
26.5.98, GB, 9811283.2
12.6.98, GB, 9812686.5
13.7.98, US, 60/092,588
13.7.98, US, 60/092,624
11.9.98, US, 60/099,948
13.10.98, GB, 9822331.6
16.10.98, GB, 9822701.0
(85) 26.5.2000
(86) 14.12.98, PCT/US98/26568
(21) 5514
(22) 26.5.2000
(41) 26.5.2000
(51) C07D 221/22; A61K 31/435; C07D
471/08; C07D 498/08; C07D 513/08
(54) Arýl sambrædd azapólýsýklísk
efnasambönd.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Jotham Wadsworth Coe, Niantic;
Paige Roanne Palmer Brooks,
North Stonington; Connecticut,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 31.12.97, US, 60/070,245
(85) 26.5.2000
(86) 13.11.98, PCT/IB98/01813
(21) 5526
(22) 9.6.2000
(41) 9.6.2000
(51) C07J 41/00; A61K 31/565; C07J 43/00;
C07J 31/00; A61K 31/58
(54) 11ß-Halógen-7alfa-setin estratríen,
aðferð til framleiðslu á lyfjasamsetningum
sem innihalda
fyrrnefnd estratríen og notkun þeirra
til framleiðslu á læknislyfjum.
(71) Schering Aktiengesellschaft,
Müllerstrasse 178, D-13353 Berlín,
Þýskalandi.
(72) Rolf Bohlmann; Nikolaus Heinrich;
Helmut Hofmeister; Jorg Kroll;
Hermann Künzer; Gerhard Sauer;
Ludwig Zorn; Karl-Heinrich
Fritzemeier; Monika Lessl;
Rosemarie Lichtner; Yukishige
Nishino; Karsten Parczyk; Martin
Schneider; Berlín, Þýskalandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 23.12.97, DE, DE 19758390.3
10.2.98, DE, DE 19806357.1
(85) 9.6.2000
(86) 23.12.98, PCT/EP98/08470
(21) 5538
(22) 16.6.2000
(41) 16.6.2000
(51) C07C 249/02; C07C 251/20
(54) Ný aðferð til framleiðslu á ketamíni.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Juan Carlos Colberg, Norwich; David
Michael Pfisterer, Mystic; Geraldine
Patricia Taber, Mystic; Connecticut,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 16.1.98, US, 60/071,600
(85) 16.6.2000
(86) 15.10.98, PCT/IB98/01619
(21) 5542
(22) 20.6.2000
(41) 20.6.2000
(51) C07D 253/06; A61K 31/53
(54) Tríazín efnasambönd til
meðhöndlunar á truflunum í
miðtaugakerfi (CNS).
(71) Glaxo Group Limited, Glaxo
Wellcome House, Berkeley Avenue,
Greenford, Middlesex UB6 ONN,
Bretlandi.
(72) Brian Cox; Mark Patrick Healy;
Malcolm Stuart Nobbs; Gita
Punjabhai Shah; Stevenage,
Hertfordshire, Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 22.12.97, GB, 9726987.2
(85) 20.6.2000
(86) 18.12.98, PCT/EP98/08273